FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013366836> ?p ?o ?g. }

• W2013366836 endingPage "2490" @default.
• W2013366836 startingPage "2482" @default.
• W2013366836 abstract "BACKGROUND: The most frequent nonhematologic side effects associated with dasatinib therapy in patients with chronic myeloid leukemia (CML) are gastrointestinal, rash, and fluid retention syndromes. However, bleeding has been observed in some patients receiving dasatinib. In the current study, the authors investigated the risk factors and management of bleeding associated with dasatinib therapy for CML after imatinib failure. METHODS: The bleeding episodes associated with dasatinib therapy in 138 patients with CML who were consecutively treated at the study institution in clinical trials were evaluated. RESULTS: Bleeding occurred in 32 (23%) patients (grade ≥3 in 9 [7%] patients [according to National Cancer Institute Common Toxicity Criteria]), including in 12% of patients treated in chronic phase, 31% of patients treated in accelerated phase (AP), and 35% of patients treated in blast phase (BP) (P = .02). The majority of episodes (81%) affected the gastrointestinal tract. Basic coagulation studies were normal in 97% of patients who developed bleeding complications. Although 37% of episodes occurred with platelet counts >100 × 109/L, multivariate analysis identified thrombocytopenia and advanced phase CML as risk factors for bleeding. A trend toward an increased risk with a twice‒daily schedule was observed (P = .17). Management included dasatinib interruption for a median of 17 days (range, 3-51 days) in 47%, of patients and transfusions in 72% of patients. CONCLUSIONS: Bleeding occurs during dasatinib therapy, particularly in patients with AP or BP disease and low platelet counts. Appropriate clinical monitoring and the timely interruption of dasatinib therapy are warranted in this subset of patients. Cancer 2009. © 2009 American Cancer Society." @default.
• W2013366836 created "2016-06-24" @default.
• W2013366836 creator A5000750846 @default.
• W2013366836 creator A5006104041 @default.
• W2013366836 creator A5015140142 @default.
• W2013366836 creator A5016607292 @default.
• W2013366836 creator A5019337932 @default.
• W2013366836 creator A5055651684 @default.
• W2013366836 creator A5077546508 @default.
• W2013366836 creator A5089428686 @default.
• W2013366836 creator A5090435894 @default.
• W2013366836 date "2009-06-01" @default.
• W2013366836 modified "2023-10-18" @default.
• W2013366836 title "Bleeding diathesis in patients with chronic myelogenous leukemia receiving dasatinib therapy" @default.
• W2013366836 cites W1973418567 @default.
• W2013366836 cites W1973720500 @default.
• W2013366836 cites W1994309500 @default.
• W2013366836 cites W2003973314 @default.
• W2013366836 cites W2011474502 @default.
• W2013366836 cites W2028959752 @default.
• W2013366836 cites W2070683532 @default.
• W2013366836 cites W2091137497 @default.
• W2013366836 cites W2092606584 @default.
• W2013366836 cites W2095443553 @default.
• W2013366836 cites W2100041900 @default.
• W2013366836 cites W2113703021 @default.
• W2013366836 cites W2116153687 @default.
• W2013366836 cites W2116385071 @default.
• W2013366836 cites W2131174104 @default.
• W2013366836 cites W2169199162 @default.
• W2013366836 cites W2171554194 @default.
• W2013366836 cites W2523641513 @default.
• W2013366836 cites W2576444306 @default.
• W2013366836 doi "https://doi.org/10.1002/cncr.24257" @default.
• W2013366836 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4180711" @default.
• W2013366836 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19280591" @default.
• W2013366836 hasPublicationYear "2009" @default.
• W2013366836 type Work @default.
• W2013366836 sameAs 2013366836 @default.
• W2013366836 citedByCount "112" @default.
• W2013366836 countsByYear W20133668362012 @default.
• W2013366836 countsByYear W20133668362013 @default.
• W2013366836 countsByYear W20133668362014 @default.
• W2013366836 countsByYear W20133668362015 @default.
• W2013366836 countsByYear W20133668362016 @default.
• W2013366836 countsByYear W20133668362017 @default.
• W2013366836 countsByYear W20133668362018 @default.
• W2013366836 countsByYear W20133668362019 @default.
• W2013366836 countsByYear W20133668362020 @default.
• W2013366836 countsByYear W20133668362021 @default.
• W2013366836 countsByYear W20133668362022 @default.
• W2013366836 countsByYear W20133668362023 @default.
• W2013366836 crossrefType "journal-article" @default.
• W2013366836 hasAuthorship W2013366836A5000750846 @default.
• W2013366836 hasAuthorship W2013366836A5006104041 @default.
• W2013366836 hasAuthorship W2013366836A5015140142 @default.
• W2013366836 hasAuthorship W2013366836A5016607292 @default.
• W2013366836 hasAuthorship W2013366836A5019337932 @default.
• W2013366836 hasAuthorship W2013366836A5055651684 @default.
• W2013366836 hasAuthorship W2013366836A5077546508 @default.
• W2013366836 hasAuthorship W2013366836A5089428686 @default.
• W2013366836 hasAuthorship W2013366836A5090435894 @default.
• W2013366836 hasBestOaLocation W20133668362 @default.
• W2013366836 hasConcept C121608353 @default.
• W2013366836 hasConcept C126322002 @default.
• W2013366836 hasConcept C141071460 @default.
• W2013366836 hasConcept C2776960273 @default.
• W2013366836 hasConcept C2777583451 @default.
• W2013366836 hasConcept C2778461978 @default.
• W2013366836 hasConcept C2778570526 @default.
• W2013366836 hasConcept C2778729363 @default.
• W2013366836 hasConcept C2779536868 @default.
• W2013366836 hasConcept C71924100 @default.
• W2013366836 hasConcept C90924648 @default.
• W2013366836 hasConceptScore W2013366836C121608353 @default.
• W2013366836 hasConceptScore W2013366836C126322002 @default.
• W2013366836 hasConceptScore W2013366836C141071460 @default.
• W2013366836 hasConceptScore W2013366836C2776960273 @default.
• W2013366836 hasConceptScore W2013366836C2777583451 @default.
• W2013366836 hasConceptScore W2013366836C2778461978 @default.
• W2013366836 hasConceptScore W2013366836C2778570526 @default.
• W2013366836 hasConceptScore W2013366836C2778729363 @default.
• W2013366836 hasConceptScore W2013366836C2779536868 @default.
• W2013366836 hasConceptScore W2013366836C71924100 @default.
• W2013366836 hasConceptScore W2013366836C90924648 @default.
• W2013366836 hasIssue "11" @default.
• W2013366836 hasLocation W20133668361 @default.
• W2013366836 hasLocation W20133668362 @default.
• W2013366836 hasLocation W20133668363 @default.
• W2013366836 hasLocation W20133668364 @default.
• W2013366836 hasOpenAccess W2013366836 @default.
• W2013366836 hasPrimaryLocation W20133668361 @default.
• W2013366836 hasRelatedWork W1967535809 @default.
• W2013366836 hasRelatedWork W1983852790 @default.
• W2013366836 hasRelatedWork W1984313504 @default.
• W2013366836 hasRelatedWork W1993369250 @default.
• W2013366836 hasRelatedWork W2092828011 @default.
• W2013366836 hasRelatedWork W2184534421 @default.

• next